Special Issue "Application of Dendrimers for Treating Parasitic and Infectious Diseases"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".

Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 249

Special Issue Editors

Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Interests: antiviral peptides; viral glycoproteins; dendrimer; natural extracts
Special Issues, Collections and Topics in MDPI journals
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Interests: antimicrobial; bacteria; dendrimer; infectious diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The emergence of the current COVID-19 pandemic has stressed the relevance of emerging and reemerging infectious diseases which constantly represent a serious concern not only for the consequences on public health, but also for their economic, social, and political impact around the world. In addition, the diffusion of multi-resistant bacteria and the insufficiency of antiviral drugs emphasize the search for innovative therapeutic strategies able to eradicate bacterial, viral, parasitic, or fungal infections. Dendrimers are very interesting platforms used as a drug delivery system in a lot of medical fields. This Special Issue aims to collect original and review contributions that deepen the most recent results on the applications of dendrimers as anti-infective agents with a special focus on their rational design, modification, and the study of their interaction with target pathogens. We look forward to receiving your contributions.

Dr. Carla Zannella
Dr. Anna De Filippis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • dendrimers
  • infectious diseases
  • antiviral
  • antibacterial
  • antiparasitic
  • antifungal

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop